(1) Yingquan Qin#, Kepeng Yan#, Dongyang Li, Jinfeng Zhang, Zongshuo Guo, Yan Zhang* and Wei Lu*. T-cell immunity in anti-tumor battle. Cellular & Molecular Immunology. 2026 Nov 04; https://doi.org/10.1038/s41423-026-01483-y.
(2) Haoyue Zhou#, Jinmei Li#, Song Mei#, Meiyu Zhang, Kepeng Yan, Qunmin Zhou, Pan Zheng, Yang Liu, Peng Zhang*, Hecheng Li*, Wei Lu*, Yan Zhang*.Specific depletion of TIGIThigh CD226- clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting. Journal for ImmunoTherapy of Cancer. 2026 Feb 24;14(2):e013636.
(3) Yu Hu#, Qifan Zhao#, Yingquan Qin#, Song Mei#, Benyu Wang, Haoyue Zhou, Linli Han , Yi Zang, Liangjiao Yao, Zhe He, Yingyi Li, Hecheng Li*, Peng Zhang*, Yan Zhang*, Michael J Lenardo*, Wei Lu*. CARD11 signaling regulates CD8+ T cell tumoricidal function. Nature Immunology. 2025 Jul;26(7):1113-1126.
(4) Meiyu Zhang#, Jinmei Li#, Kepeng Yan#, Haoyue Zhou, Song Mei, Benyu Wang, Dongyang Li, Xuexiang Du, Mingyue Liu, Peng Zhang, James K Fields, Lei Ye, Pan Zheng, Yang Liu, Michael J Lenardo*, Yan Zhang*. pH-dependent dissociation from CTLA-4 in early endosomes improves both safety and antitumor activity of anti-CTLA-4 antibodies. Proceedings of the National Academy of Sciences of the United States of America. 2025 Feb 25;122(8):e2422731122.
(5) Zhenyi Niu, Ruisen Jin, Yan Zhang*, Hecheng Li*. Signaling pathways and targeted therapies in lung squamous cell car cinoma: mechanisms and clinical trials. Signal Transduction and Targeted Therapy. 2022 Oct 5;7(1):353.
(6) Pan Jia, Xiang Li, Xuelei Wang, Liangjiao Yao, Yingying Xu, Yu Hu, Wenwen Xu, Zhe He, Qifan Zhao, Yicong Deng, Yi Zang, Meiyu Zhang, Yan Zhang*, Jun Qin*, Wei Lu*. ZMYND8 mediated liquid condensates spatiotemporally decommission the latent super-enhancers during macrophage polarization. Nature Communications. 2021 Nov 11;12(1):6535.
(7) Wei Zheng#, Yan Zhang#, Jingjing Chen#, Yu Hu#, Pan Jia, Xuelei Wang, Qifang Zhao, Yicong Deng, Ni Li, Yi Zhang, Jun Qin, Xiaoming Wang*, Wei Lu*. Pathogenic CARD11 mutations affect B cell development and differentiation through a noncanonical pathway. Science Immunology. 2019 Nov 29;4(41):eaaw5618.
(8) Yan Zhang#*, Xuexiang Du#, Mingyue Liu#, Fei Tang, Peng Zhang, Chunxia Ai, James K. Fields, Eric J. Sundberg, Olga S. Latinovic, Martin Devenport, Pan Zheng*, Yang Liu*. Hijacking Antibody-induced CTLA-4 Lysosomal Degradation for Safer and More Effective Cancer Immunotherapy, Cell Research. 2019 29: 609-627.
(9) Yan Zhang, Swati Chokis, Kun Chen, Yelena Pobezinskaya, Ilona Linnoila, Zhenggang Liu*. ROS plays a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor associated macrophages, Cell Research. 2013 23: 898-914.
(10) Yan Zhang, Michael Morgan, Ken Chen, Swati Choksi, Zhenggang Liu*. Induction of Autophagy is Essential for Monocyte-Macrophage Differentiation. Blood. 2012 119(12): 2895-2905.
(11) Yan Zhang#, Yi Ba#, Chang Liu, Guoxun Sun, Li Ding, Songyuan Gao, Jihui Hao, Zhentao Yu, Junfeng Zhang, Ke Zen, Zhongsheng Tong, Yang Xiang, Chen-Yu Zhang*.PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway, Cell Research. 2007 17: 363-373.
(1) 通过靶向Treg解偶联肿瘤免疫治疗中自身免疫副作用的关键机制研究. 国家自然科学基金面上项目, 82071866
(2) 组蛋白修饰阅读分子ZMYND8特异性调控胸腺Treg影响肿瘤免疫的机制研究. 国家自然科学基金面上项目, 82271762
(3) TIGIT单抗在CTLA-4靶向肿瘤治疗中的协同作用. 上海市自然科学基金面上项目, 22ZR1454800
(4) 耗竭前体T细胞依赖的三级淋巴结构在食管鳞癌响应免疫治疗中的功能研究. 国家自然科学基金青年项目, 82403856
(5) IgG+浆细胞驱动EGFR-TKI耐药非小细胞肺癌对PD-1治疗响应的机制研究. 国家自然科学基金青年项目, 82503111
(6) CTLA-4hi KLRG1+组织驻留Treg在免疫检查点抑制剂相关心肌炎中的关键调节机制. 国家自然科学基金青年项目, 82502217
(7) CTLA-4hi KLRG1+组织驻留Treg在肿瘤免疫治疗相关副作用中的关键作用. 上海市自然科学基金青年项目,25ZR1402452
(8) EGFR-TKI耐药非小细胞肺癌免疫微环境中T细胞耗竭的影响因素及应答免疫治疗的机制探究. 中国博士后科学基金面上项目, 2024M752006
(9) 启动基金. 上海交通大学医学院/上海市免疫学研究所, KJ2-0101-22-6330